2019. Comparative efficacy of spironolactone, eplerenone, nebivolol and moxonidine in patients with resistant arterial hypertension. Ukrainian Journal of Cardiology. 25, 6 (Jan. 2019), 65–71. DOI:https://doi.org/10.31928/1608-635X-2018.6.6571.